Arxis, Inc. Class A Common Stock (ARXS)vsRTX Corporation (RTX)
ARXS
Arxis, Inc. Class A Common Stock
$39.41
-6.12%
INDUSTRIALS · Cap: $16.82B
RTX
RTX Corporation
$180.99
-0.37%
INDUSTRIALS · Cap: $234.67B
Smart Verdict
WallStSmart Research — data-driven comparison
RTX Corporation generates 5312% more annual revenue ($90.37B vs $1.67B). RTX leads profitability with a 8.0% profit margin vs 6.2%. RTX trades at a lower P/E of 32.7x. RTX earns a higher WallStSmart Score of 59/100 (C).
ARXS
Hold36
out of 100
Grade: F
RTX
Buy59
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 24.2%
Revenue surging 20.7% year-over-year
Mega-cap, among the largest globally
Earnings expanding 32.5% YoY
Generating 1.2B in free cash flow
Areas to Watch
0.0% earnings growth
6.2% margin — thin
Premium valuation, high expectations priced in
ROE of -1.6% — below average capital efficiency
Expensive relative to growth rate
Premium valuation, high expectations priced in
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : ARXS
The strongest argument for ARXS centers on Operating Margin, Revenue Growth. Revenue growth of 20.7% demonstrates continued momentum.
Bull Case : RTX
The strongest argument for RTX centers on Market Cap, EPS Growth, Free Cash Flow.
Bear Case : ARXS
The primary concerns for ARXS are EPS Growth, Profit Margin, P/E Ratio. A P/E of 2049.3x leaves little room for execution misses.
Bear Case : RTX
The primary concerns for RTX are PEG Ratio, P/E Ratio, Altman Z-Score.
Key Dynamics to Monitor
ARXS profiles as a growth stock while RTX is a value play — different risk/reward profiles.
ARXS is growing revenue faster at 20.7% — sustainability is the question.
RTX generates stronger free cash flow (1.2B), providing more financial flexibility.
Monitor AEROSPACE & DEFENSE industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RTX scores higher overall (59/100 vs 36/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arxis, Inc. Class A Common Stock
INDUSTRIALS · AEROSPACE & DEFENSE · USA
Arxis, Inc. (ARXS) is a leading biotechnology firm dedicated to pioneering advanced therapeutics for complex diseases. The company has a strong focus on research and development, channeling resources into its innovative drug pipeline that addresses both rare and widespread medical conditions. By fostering collaborative partnerships and engaging in robust clinical programs, Arxis is committed to enhancing patient outcomes. As it advances through various clinical trial phases, Arxis is strategically positioned for significant growth, presenting compelling value creation opportunities for institutional investors in the evolving biotech landscape.
RTX Corporation
INDUSTRIALS · AEROSPACE & DEFENSE · USA
Raytheon Technologies Corporation is an American multinational aerospace and defense conglomerate headquartered in Waltham, Massachusetts. It is one of the largest aerospace, intelligence services providers, and defense manufacturers in the world by revenue and market capitalization. Raytheon Technologies (RTX) researches, develops, and manufactures advanced technology products in the aerospace and defense industry, including aircraft engines, avionics, aerostructures, cybersecurity, guided missiles, air defense systems, satellites, and drones.
Visit Website →Compare with Other AEROSPACE & DEFENSE Stocks
Want to dig deeper into these stocks?